The use of GLP-1 RAs may be appropriate among select patients with psoriasis, although additional research is needed to guide ...

A review highlights new and emerging treatments for generalized pustular psoriasis, with a focus on IL-36 inhibitors.

Ixekizumab plus tirzepatide improved psoriasis clearance and weight loss in adults with obesity. Find out more about the ...

USA: A clinical trial has found that combining tirzepatide with ixekizumab led to significant improvements in skin clearance ...

FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of therapeutics and potential cures ...

Alert Pediatric Plaque Psoriasis Treatment Set to Expand in Europe European regulators have recommended expanding use of the IL-23 inhibitor Skyrizi to treat moderate-to-severe plaque psoriasis in ...

These stars may have access to some of the most elite doctors and makeup teams in the world, but they still have the same ...

Higher comorbidity burden, uveitis, and psoriasis are independently associated with accelerated spinal radiographic ...

Johnson & Johnson is rated Hold, trading near intrinsic value with limited upside based on a 20x multiple and $12 normalized EPS. Q1 results showed 10% sales growth and a $450M revenue beat, with ...

Regional Queensland is facing a shortage of dermatologists, leaving some patients increasingly desperate.

UCB’s Bimzelx elicited significantly stronger joint relief at 16 weeks than AbbVie’s Skyrizi in a Phase 3 head-to-head study ...

With better screening for type 1 diabetes and a new treatment called TZield, the outlook is improving for people with the ...